Summary
The pharmacokinetic of 4′-deoxydoxorubicin, a new analog of doxorubicin, was compared with that of its parent compound in mice treated with equal and equiactive doses. The levels of total fluorescence due to the initial drugs and to metabolites were determined in tissue extracts by fluorometry. 4′-Deoxydoxorubicin reached the same tissue levels as doxorubicin in all the organs tested except in spleen and lung, where a higher peak was found in the animals treated with the new analog. The rate of elimination of 4′-deoxydoxorubicin from the organs tested was higher than that of doxorubicin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arcamone F, Penco S, Redaelli S (1976) Synthesis and antitumor activity of 4′-deoxydaunorubicin and 4′-deoxyadriamycin. J Med Chem 19: 1424
Bachur NR, Moore AL, Berustein JG, Lin A (1970) Tissue distribution and disposition of daunomycin (NSC-82151) in mice: fluorometric and isotopic methods. Cancer Chem Rep 54: 89
Bertazzoli C, Chieli T, Grandi M, Ricevuti G (1970) Adriamycin: Toxicity data. Experientia 26: 389
Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2: 123
Casazza AM, Di Marco A, Bonadonna G, Bonfante V, Bertazzoli C, Bellini O, Pratesi G, Sala L, Ballerini L (1980) Effects of modifications in position 4 of the chromophore or in position 4′ of the aminosugar, on the antitumor activity and toxicity of daunorubicin and doxorubicin. In: Crooke ST, Reich SD (eds) Anthracycline: current status and new developments. Academic Press, London, pp 403–430
Di Marco A, Casazza AM, Dasdia T, Necco A, Pratesi G, Rivolta P, Velcich A, Zaccara A, Zunino F (1977) Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety. Chem Biol Interact 19: 291
Formelli F, Casazza AM, Di Marco A, Mariani A, Pollini C (1979) Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumours. Cancer Chemother Pharmacol 3: 261
Giuliani F, Bellini O, Casazza AM, Formelli F, Savi G, Di Marco A (1978) Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M induced sarcoma. Eur J Cancer 14: 555
Marquardt DW (1966) Least squares estimation of nonlinear parameters, a computer program in FORTRAN IV language. IBM SHARE library, distribution no. 309401. August, 1966
Schwartz HS (1973) A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem Med J 7: 396
Yesair DW, Schwartzbach E, Shuck D, Denine EP, Asbell MA (1972) Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. Cancer Res 32: 1177
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Formelli, F., Pollini, C., Casazza, A.M. et al. Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors. Cancer Chemother. Pharmacol. 5, 139–144 (1981). https://doi.org/10.1007/BF00258470
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258470